Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation, reflects on landmark research undertaken by the charity ahead of World COPD Day, including the largest ever survey of people with COPD in the UK.
Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation, reflects on landmark research undertaken by the charity ahead of World COPD Day, including the largest ever survey of people with COPD in the UK.
Zak Bond, Policy Officer at the British Lung Foundation, explores why the government must commit to stronger air pollution targets to protect our lungs as we recover from COVID-19.
Michael Roth discusses soluble circulating cytokine receptors in chronic inflammatory lung diseases, which he describes as the under-estimated regulators of inflammation and remodelling.
According to Maximilian Kunisch and Giuseppe De Carlo from the European Federation of Allergies and Airways Diseases Patients' Associations, respiratory patients in Europe need to set the research priorities for asthma and chronic obstructive pulmonary disease (COPD).
More can be done at the local, national and EU level to improve COPD diagnosis, support smoking cessation and advance work and living conditions for people living with COPD.
Katy Beckford and Alex Christie from the Association of Respiratory Nurse Specialists detail precisely why dyspnoea (breathlessness) remains an ongoing battle today
Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases
